Positive Trial Results Released for Alpha-1 Antitrypsin Deficiency-Associated Emphysema Treatment

Mereo BioPharma Group has just announced positive results from their Phase 2 study called ASTRAEUS. This study investigated alvelestat (MPH-966), which is an oral neutrophil elastase inhibitor, as a treatment…

Continue Reading Positive Trial Results Released for Alpha-1 Antitrypsin Deficiency-Associated Emphysema Treatment
Family Hopes to Raise Sanfilippo Syndrome Awareness through #ChaseTheSigns Campaign
source: pixabay.com

Family Hopes to Raise Sanfilippo Syndrome Awareness through #ChaseTheSigns Campaign

When Sophia Scott was growing up, her parents noticed that she was displaying a variety of different potentially concerning traits. They began undergoing some tests. Eventually, just one day before…

Continue Reading Family Hopes to Raise Sanfilippo Syndrome Awareness through #ChaseTheSigns Campaign
The First Patient has Been Dosed in a Clinical Trial for Primary Biliary Cholangitis Treatment
source: pixabay.com

The First Patient has Been Dosed in a Clinical Trial for Primary Biliary Cholangitis Treatment

Gannex has just announced that they have dosed the first patient in their Phase 2 clinical trial examining ASC42 as a treatment for those diagnosed with primary biliary cholangitis (PBC).…

Continue Reading The First Patient has Been Dosed in a Clinical Trial for Primary Biliary Cholangitis Treatment
A Teacher in the UK With Myalgic Encephalomyelitis was Advised to Exercise for Rapid Recovery
source: pixabay.com

A Teacher in the UK With Myalgic Encephalomyelitis was Advised to Exercise for Rapid Recovery

  Many in the medical profession believed that the road to rapid recovery in myalgic encephalomyelitis was through exercise. Eighty-two-year-old Veronica Jones of Gloucestershire, UK believes that the advice given…

Continue Reading A Teacher in the UK With Myalgic Encephalomyelitis was Advised to Exercise for Rapid Recovery
Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage
Source: https://unsplash.com/photos/ZHys6xN7sUE

Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage

  What happens when you treat your condition, but the medication isn’t effective? Sometimes, other approved medications are beneficial for patient use, but other times, there are no approved medications.…

Continue Reading Jyseleca for Ulcerative Colitis Approved in Scotland for NHS Coverage
This Myalgic Encephalomyelitis Patient is Returning to the Workplace
source: pixabay.com

This Myalgic Encephalomyelitis Patient is Returning to the Workplace

According to a story from BBC, 28 year old Saskia James has struggled with myalgic encephalomyelitis (also called chronic fatigue syndrome) for years, which began with the onset of seizures…

Continue Reading This Myalgic Encephalomyelitis Patient is Returning to the Workplace
May is Neurofibromatosis Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

May is Neurofibromatosis Awareness Month: Spreading Rare Disease Awareness

According to a story from the Children's Tumor Foundation (CTF), the month of May is recognized as Neurofibromatosis (NF) Awareness Month. This is a time for spreading awareness about neurofibromatosis…

Continue Reading May is Neurofibromatosis Awareness Month: Spreading Rare Disease Awareness
A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
source: pixabay.com

A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon

According to a story from Globe Newswire, The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recently announced a positive opinion in regards to the experimental…

Continue Reading A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV
qimono / Pixabay

Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

The new FDA-approved oral formulation of  Radicava ORS (edaravone) is more convenient than the intravenous formulation, yet the efficacy and composition remain the same. The oral formulation may also be…

Continue Reading Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

Patient Story: Breaking the Stereotypes Around ME

According to a recent article, 82-year-old Veronica Jones is working to break the laziness stigma that surrounds a myalgic encephalomyelitis diagnosis. Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) Myalgic encephalomyelitis (ME),…

Continue Reading Patient Story: Breaking the Stereotypes Around ME